| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.2 | 9e-07 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.21 | 5e-06 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-05 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.16 | 0.0001 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.16 | 0.0001 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.25 | 0.0003 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0004 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.2 | 0.0006 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.21 | 0.0007 |